Quinz advises leading healthcare and life sciences clients on transactional, regulatory, compliance, and dispute resolution matters, with a strong focus on domestic and international projects. The firm is recognised for supporting European R&D and supply chain transactions and coordinating cross-border regulatory analyses. Co-heads Olivier Van Obberghen and Pieter Wyckmans specialise in pharmaceutical compliance, regulatory, and strategic transactions, while Marion Lapage provides operational assistance throughout the full product lifecycle.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Billing & efficiency
Testimonials
Collated independently by Legal 500 research team.
- ‘In addition to being excellent lawyers, Quinz's Healthcare and Life Sciences team also has a deep understanding of a pharmaceutical company's business needs. The team is able to support our company as an extension of our Legal Department. The lawyers from this team can seamlessly step in if an in-house counsel is out on unexpected leave. This is a rare and extremely valuable skill for an external law firm.’
- ‘Quinz is unique in the way it combines top-tier legal knowledge with a true spirit of partnership. In working with them, we value their openness, pragmatism, and ability to make complex matters workable across borders.'
- ‘The individuals at Quinz stand out not only for their deep legal expertise but also for their remarkable collegiality and client-minded approach. We have been consistently impressed by their ability to combine sharp technical skills with a pragmatic, solution-oriented mindset.'
- ‘The practice stands out for the strong complementarity within its team — both in expertise and personal style. Each lawyer brings deep knowledge in their own field, yet collaboration is at the core of how the team operates. Matters are consistently discussed and refined collectively, ensuring that strategic, regulatory, and transactional angles are aligned from the outset.'
- ‘I work with both Pieter Wyckmans and Olivier Van Obberghen from Quinz. They both deliver excellent work. While their personal styles differ slightly, they share the same strengths: thorough and high-quality legal analysis, combined with a pragmatic approach and a deep understanding of the life sciences industry. This balance between technical precision and practical insight makes their advice particularly valuable and effective.’
Key clients
- Johnson & Johnson
- UCB Pharma
- Takeda
- Galapagos
- Telix Pharmaceuticals
- Vertex
- Bayer
- ExeVir
- Abscint
- Priothera
- IPOPI
- Sciensano
Work highlights
Advised KCE on legal and regulatory strategies for advanced therapy medicinal products, helping non-profit and academic developers overcome obstacles, shape ATMP policy, and expand patient access.
Advised Sightera Biosciences on drafting and negotiating its in-licensing agreement for oncology patents, AI software and data with the University of Antwerp and Antwerp University Hospital.
Advised Boehringer-Ingelheim on a daily basis across a broad range of regulatory compliance matters, including the promotion of human and veterinary medicinal products, design of discount strategies, compliance with Belgian and EU regulations, and effective engagement with the FAMHP, while also advising on patient support programs.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Olivier Van Obberghen; Pieter Wyckmans
Other key lawyers
Marion Lapage; Amber Cockx; Dries Vanpaemel